Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,256.00    -24.00 (-1.88%)
Bid:
1,246.00
Ask:
1,258.00
Spread: 12.00 (0.963%)
Market Cap: £575.57m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

Director/PDMR Shareholding

10 Aug 2022 14:59

RNS Number : 6060V
Cohort PLC
10 August 2022
 

One Waterside Drive

Arlington Business Park

Reading

Berks

RG7 4SW

 

 

 

10 August 2022

 

 

 

 

 

COHORT PLC

("Cohort" or "the Group")

 

Director Shareholdings

Cohort plc wishes to notify the following changes in the interests of directors of the Company in ordinary shares of 10 pence ("Ordinary Shares") in relation to share awards and share options.

 

Transfer of Share Awards

On 7 and 9 August 2022, Ordinary Shares that had vested from awards in accordance with the rules of the 2013 Restricted Share Scheme established on 30 July 2013 (the "Restricted Share Scheme") were transferred to the executive directors of the Company (the "Transfers"). The following table sets out the details of the Transfers:

 

Director

Total number of Ordinary Shares vested on 7 August

Total number of Ordinary Shares vested on 9 August

Total number of unvested Ordinary Shares under the Restricted Share Scheme following Grant and Transfers

AS Thomis

3,693

7,573

9,204

SR Walther

2,889

5,925

7,201

 

Full ownership of Ordinary Shares awarded under the Restricted Share Scheme (including voting and dividend rights) transfers to the recipients in four stages; 25% on award and a further 25% on the first, second and third anniversaries of the award. Recipients may only sell shares awarded under the Restricted Share Scheme with the approval of the Chairman of the Remuneration Committee while they remain in employment with the Company. Further details regarding the Restricted Share Scheme can be found in the Company's Annual Report and Accounts 2021.

 

Director Shareholdings

Following completion of the transactions detailed above, the interests of Mr Thomis and Mr Walther and their connected persons in the shares of Cohort plc will be as follows:

 

Director

Ordinary Shares*

% of the total issued share capital

AS Thomis

225,419

0.55

SR Walther

214,352

0.52

*Not including unvested shares under the Restricted Share Scheme

 

 

NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Andrew Thomis

2

Reason for the notification

a)

Position/status

Chief Executive

b)

Initial notification/amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Cohort plc

b)

Legal Entity Identifier Code

213800WE61C73LZZNW11

4

Details of the transaction(s)

a)

Description of the financial instrument, type of instrument

Ordinary shares in Cohort plc with a nominal value of 10 pence each

b)

Identification Code

GB00B0YD2B94

c)

Nature of the transaction

Vesting of shares under the Cohort plc 2013 Restricted Share Scheme and transfer to a nominee account in the name of Andrew Thomis

d)

Currency

GBP - British Pound

e)

Price(s) and Volume(s)

11,266 Ordinary Shares at 0.00 pence

f)

Aggregated Information

- Price

- Volume

- Total

N/A

g)

Date of transaction

7 and 9 August 2022

h)

Place of transaction

Outside of a Main Market

 

 

 

 

NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Simon Walther

2

Reason for the notification

a)

Position/status

Finance Director

b)

Initial notification/amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Cohort plc

b)

Legal Entity Identifier Code

213800WE61C73LZZNW11

4

Details of the transaction(s)

a)

Description of the financial instrument, type of instrument

Ordinary shares in Cohort plc with a nominal value of 10 pence each

b)

Identification Code

GB00B0YD2B94

c)

Nature of the transaction

Vesting of shares under the Cohort plc 2013 Restricted Share Scheme and transfer to a share certificate in the name of Simon Walther

d)

Currency

GBP - British Pound

e)

Price(s) and Volume(s)

8,814 Ordinary Shares at 0.00 pence

f)

Aggregated Information

- Price

- Volume

- Total

N/A

g)

Date of transaction

7 and 9 August 2022

h)

Place of transaction

Outside of a Main Market

 

 

Ends

 

 

For further information please contact:

Cohort plc

0118 909 0390

Andy Thomis, Chief Executive

Simon Walther, Finance Director

Raquel McGrath, Company Secretary

Investec Bank Plc (NOMAD and Broker)

020 7597 5970

Daniel Adams, Christopher Baird

MHP Communications

020 3128 8570

Reg Hoare, Ollie Hoare, Pete Lambie

cohort@mhpc.com

 

 

NOTES TO EDITORS

 

Cohort plc (www.cohortplc.com) is the parent company of six innovative, agile and responsive businesses based in the UK, Germany and Portugal, providing a wide range of services and products for domestic and export customers in defence and related markets.

 

Chess Technologies, through its operating businesses Chess Dynamics and Vision4ce, offers surveillance, tracking and fire-control systems to the defence and security markets. A majority stake was acquired by Cohort plc in December 2018. www.chess-dynamics.com 

 

EID designs and manufactures advanced communications systems for naval and military customers. Cohort acquired a majority stake in June 2016. www.eid.pt

 

ELAC SONAR supplies advanced sonar systems and underwater communications to global customers in the naval marketplace. Acquired by Cohort in December 2020. www.elac-sonar.de 

 

MASS is a specialist data technology company serving the defence and security markets, focused on electronic warfare, digital services and training support. Acquired by Cohort in August 2006. www.mass.co.uk

 

MCL designs, sources and supports advanced electronic and surveillance technology for UK end users including the MOD and other government agencies. MCL has been part of the Group since July 2014. www.marlboroughcomms.com

 

SEA delivers and supports technology-based products for the defence and transport markets alongside specialist research and training services. Acquired by Cohort in October 2007. www.sea.co.uk

 

Cohort (AIM: CHRT) was admitted to London's Alternative Investment Market in March 2006. It has headquarters in Reading, Berkshire and employs in total over 1,000 core staff there and at its other operating company sites across the UK, Germany and Portugal.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBXGDIIUBDGDG
Date   Source Headline
1st Jun 202611:41 amRNSTotal Voting Rights
27th May 20267:00 amRNSFull Year Trading Update
26th May 20267:00 amRNSNotice of Full Year Trading Update
12th May 202610:46 amRNSHolding(s) in Company
1st May 20269:37 amRNSTotal Voting Rights
10th Apr 20263:58 pmRNSDirector/PDMR Shareholding
10th Apr 202612:35 pmRNSHolding(s) in Company
2nd Apr 20267:00 amRNSBlock Listing Six Monthly Return
1st Apr 202610:10 amRNSTotal Voting Rights
26th Mar 20267:00 amRNSContract Announcement
23rd Mar 20267:00 amRNSContract Announcement
2nd Mar 202611:57 amRNSTotal Voting Rights
25th Feb 20269:51 amRNSBlock Listing Six Monthly Return
20th Feb 20267:00 amRNSDirector/PDMR Shareholding
17th Feb 20263:41 pmRNSHolding(s) in Company
16th Feb 20267:00 amRNSDirector/PDMR Shareholding
4th Feb 20269:35 amRNSHolding(s) in Company
2nd Feb 20264:54 pmRNSTotal Voting Rights
30th Jan 20267:00 amRNSContract Wins
20th Jan 202612:40 pmRNSHolding(s) in Company
15th Jan 20267:00 amRNSInterim Report 2025
5th Jan 20269:00 amRNS-RInvestor Presentation via Equity Development
2nd Jan 202612:40 pmRNSTotal Voting Rights
22nd Dec 20259:00 amRNS-RInvestor Presentation via Engage Investor
22nd Dec 20259:00 amRNS-RInvestor Presentation via Engage Investor
15th Dec 202511:56 amRNSDirector/PDMR Shareholding
11th Dec 20257:00 amRNSDirector/PDMR Shareholding
10th Dec 20257:01 amRNSHalf Year Results
1st Dec 202512:20 pmRNSTotal Voting Rights
28th Nov 20257:00 amRNSNotice of Half Year Results
4th Nov 202511:59 amRNSTotal Voting Rights
27th Oct 20254:37 pmRNSDirector/PDMR Shareholding
16th Oct 202510:11 amRNSDirector/PDMR Shareholding
7th Oct 20253:15 pmRNSDirector/PDMR Shareholding
7th Oct 20257:00 amRNSMASS secures £15.7m countermeasures contract
2nd Oct 202511:03 amRNSBlock Listing Six Monthly Return
1st Oct 20259:53 amRNSTotal Voting Rights
25th Sep 20254:59 pmRNSResult of AGM
25th Sep 20257:00 amRNSAGM Statement
19th Sep 20255:12 pmRNSDirector/PDMR Shareholding
12th Sep 20257:00 amRNS-RInvestor Presentation
10th Sep 20253:21 pmRNSDirector/PDMR Shareholding
3rd Sep 202510:57 amRNSDirector/PDMR Shareholding
1st Sep 202511:05 amRNSTotal Voting Rights
26th Aug 20253:22 pmRNSBlock Listing Six Monthly Return
20th Aug 20253:56 pmRNSAnnual Report and Notice of Annual General Meeting
15th Aug 20253:35 pmRNSDirector/PDMR Shareholding
11th Aug 20255:10 pmRNSDirector/PDMR Shareholding
1st Aug 20254:16 pmRNSTotal Voting Rights
17th Jul 20259:49 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.